February 5, 2019 7:57am
Proceed with caution …
Sustainability is a capability, not a certainty
Quarterly results: Sage Therapeutics (SAGE) - 2/19 joins the queue of Organovo (ONVO) -2/7 and Alnylam Pharmaceuticals (ALNY) – 2/7 and BioMarin pharmaceuticals (BMRN) – 2/21
Pre-open indications: 1 BUY, 2 SELLs and 3 trades
Skim if you can trim, buy if it will fly and sell if compelled!
Members only. Please login.